News
NRXBF
0.476
NaN%
--
BRIEF-Nurexone Biologic’S U.S. Subsidiary Exo-Top And Florida-Based Bioxtek Sign Strategic Loi For Exosome Manufacturing And Commercialization
Reuters · 6h ago
Weekly Report: what happened at NRXBF last week (0330-0403)?
Weekly Report · 1d ago
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
Barchart · 6d ago
Weekly Report: what happened at NRXBF last week (0323-0327)?
Weekly Report · 03/30 10:36
NurExone attends INVEST 2026; NANO.IL.2026 conference is postponed
Reuters · 03/28 06:25
NUREXONE BIOLOGIC INC - NO MONETARY CONSIDERATION OR SUBLICENSE FEES EXPECTED FOR EXO-TOP SUBLICENSE
Reuters · 03/26 20:03
Weekly Report: what happened at NRXBF last week (0316-0320)?
Weekly Report · 03/23 10:32
Weekly Report: what happened at NRXBF last week (0309-0313)?
Weekly Report · 03/16 10:31
NurExone Biologic closes private placement raising CAD 0.88 million
Reuters · 03/11 12:28
NurExone Announces Corporate Updates
Barchart · 03/11 07:28
Weekly Report: what happened at NRXBF last week (0302-0306)?
Weekly Report · 03/09 10:31
NurExone Biologic Takes Exosome Platform to NANO.IL.2026 Conference
Reuters · 03/07 06:00
NurExone Biologic to Showcase Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress
Reuters · 03/04 09:34
Weekly Report: what happened at NRXBF last week (0223-0227)?
Weekly Report · 03/02 10:30
NurExone Biologic Confirms Consistent Exosome Batch Production in Independent Analysis
Reuters · 02/28 07:23
NurExone Biologic Inc. to Showcase Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress
Reuters · 02/27 21:03
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Barchart · 02/27 15:03
Weekly Report: what happened at NRXBF last week (0216-0220)?
Weekly Report · 02/23 10:30
NurExone Biologic Reports Independent Proteomic Analysis Confirming Exosome Batch Consistency
Reuters · 02/21 07:30
Weekly Report: what happened at NRXBF last week (0209-0213)?
Weekly Report · 02/16 10:30
More
Webull provides a variety of real-time NRXBF stock news. You can receive the latest news about Nurexone Biologic Inc through multiple platforms. This information may help you make smarter investment decisions.
About NRXBF
Nurexone Biologic Inc is an Israel-based company engaged primarily in the pharmaceutical sector. The Company is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s flagship product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. The Company focuses on research and development of pharmaceutical technologies.